x
ServiziMenu principaleHome
You are here: Home > What we do > Past events > 2014 > 4th EASO Masterclass in Clinical Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

4th EASO Masterclass in Clinical Oncology

30 ESCO credits

20.06.2014  -  22.06.2014

Casablanca, Morocco

MASTERCLASS

Medical / clinical oncology

Description

Chair: R. Gaafar, EG - N. Pavlidis, GR 
Host Chair: A. Benider, MA

General information

ORGANISING SECRETARIAT               
Daniela Mengato
Euro-Arab School of Oncology (EASO)            
Via Turati 29                       
20121 - Milan, Italy                   
Ph: +39 02 85464523
Fax: +39 0285464545                                           
Email: easo@eso.net


VENUE
Golden Tulip Farah Casablanca
160, Av Des Forces Armees Royales
Casablanca - Morocco
Tel: +212 5 22 311212
www.goldentulipfarahcasablanca.com


OFFICIAL LANGUAGE
The official language of the course will be English and fluency in English is necessary for admission. No simultaneous translation will be provided.


BADGE
The badge is the only official evidence of registration and should be worn at all times during the masterclass. Loss of badge means loss of registration.


INSURANCE
The organisers bear no responsibility for untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel insurance coverage.



IDEAL MASTERCLASS CANDIDATE
- Age up to 40 years
- 2-3 years’ experience mainly in clinical oncology
- Involvement in scientific activities
- Fluency in English


Faculty list


FACULTY
N. Allahloubi
, National Cancer Institute, Cairo University, EG
H.A. Azim Jr.
, Institut Jules Bordet, Breast Data Centre, Brussels, BE
N. Benchakroun
, Centre Hospitalier Universitaire, IBN Rochid, Casablanca, MA
A. Benider
, Centre Mohamed VI pour le Traitement du Cancer, Casablanca, MA
N. Benjaafar
, National Institute of Oncology, Rabat, MA
G. Ceresoli
, Istituto Humanitas Gavazzeni, Bergamo, IT
M. Di Maio
, National Cancer Institute, Naples, IT
C. Doglioni
, San Raffaele Scientific Institute, Milan, IT
H. Errihani
, National Institute of Oncology, Rabat, MA
R. Gaafar
, National Cancer Institute, Cairo University, EG
R. Garcìa Carbonero
, Hospital Universitario Virgen Del Rocio, Sevilla, ES
F. Geara
, American University of Beirut Medical Center, LB
H. Jouhadi
, Centre Hospitalier Universitaire, IBN Rochid, Casablanca, MA
J. Khader
, King Hussein Cancer Centre, Amman, JO
H. Khaled
, National Cancer Institute, Cairo University, EG
R. Labianca
, Ospediali Riuniti, Bergamo, IT
O. Michielin
, Lausanne University Hospital - CHUV, Lausanne, CH
A. Morsi
, National Cancer Institute, Cairo University, EG
O. Pagani
, Oncology Institute of Southern Switzerland, Bellinzona, CH
N. Pavlidis
, University of Ioannina, School of Medicine, Ioannina, GR
F. Peccatori
, European Institute of Oncology, Milan, IT
A. Quessar
, Centre Hospitalier Universitaire, IBN Rochid, Casablanca, MA
J. Romero-Otero
, Hospital Universitario 12 de Octubre, Madrid, ES
S. Sahraoui
, Centre Hospitalier Universitaire, IBN Rochid, Casablanca, MA
A. Shamseddine
, American University of Beirut Medical Center, LB
M. Sughayer
, King Hussein Cancer Centre, Amman, JO
N. Tawfiq
, Centre Hospitalier Universitaire, IBN Rochid, Casablanca, MA
J.B. Vermorken
, University Hospital of Antwerp, Edegem, BE
O.Z. Youssef
, National Cancer Institute, Cairo University, EG
E. Zucca
, Oncology Institute of Southern Switzerland, Bellinzona, CH

 

.

Programme


 20 June
 
    
 8:10
  Welcome address
R. Gaafar, EG - N. Pavlidis, GR
8:15  Introduction: The Euro-Arab School of Oncology (EASO): Eight years of activity
N. Pavlidis, GR
LUNG CANCER
Chairs: R. Gaafar, EG - N. Benjaafar, MA
8:30  The contribution of molecular pathology in the diagnosis and treatment of lung cancer
M. Sughayer, JO
9:00  Radiation treatment of lung cancer: an update 
F. Geara, LB
9:30  Targeted therapy of advanced non-small cell lung cancer
R. Gaafar, EG
10:00  Tumour board (2-3 cases)
11:00  Prayer and lunch break
COLORECTAL CANCER
Chairs: R. Labianca, IT - N. Tawfiq, MA
14:00  The principles of surgery in colorectal cancer
A. Morsi, EG
14:30
  Adjuvant and neoadjuvant therapy of colorectal cancer
R. Labianca, IT
14:50
   The role of radiotherapy in the management of rectal and anal cancer 
J. Khader, JO
 15:20  Systemic treatment of colorectal cancer in metastatic disease
R. Labianca, IT
 15:50  Tumour board (2 cases)
16:30  Coffee break
Chairs: R. Garcia-Carbonero, ES - N. Tawfiq, MA
 17:00  Spotlight: the management of GI neuroendocrine tumours
Speaker to be confrimed
17:30  Spotlight: treatment of hepatocellular carcinoma: is there any progress?
M. Di Maio, IT
    

21 June

 

    
BREAST CANCER
Chairs: O. Pagani, CH - H. Errihani, MA
8:30
  The role of surgery in breast cancer
O.Z. Youssef, EG
9:00  The role of gene expression signatures in adjuvant breast cancer
H.A. Azim Jr., BE
9:30  Indications of radiation therapy in early breast cancer
F. Geara, LB
10:00  Neoadjuvant  and adjuvant chemotherapy and targeted treatments
O. Pagani, CH
10:30  Neoadjuvant  and adjuvant hormonal therapy treatment
N. Allahloubi, EG
11:00  Coffee break
11:30  Systemic treatment of advanced disease
O. Pagani, CH
12:30  Breast cancer in young women: impact of pregnancy on biology and outcome
F. Peccatori, IT
12:30   Tumour board (2-3 cases)
 13:30  Lunch break
PROSTATE CANCER
Chairs: A. Shamseddine, LB - H. Jouhadi, MA
 14:30   The principles of surgery in prostate cancer
J. Romero-Otero, ES
 15:00  Radiation therapy of prostate cancer
J. Khader, JO
 15:30  Systemic treatment in prostate cancer 
A. Shamseddine, LB
 16:00  Coffee break
 16:30  Tumour board (2-3 cases)
    
 22 June
    
LYMPHOMA
Chairs: E. Zucca, CH - A. Quessar, MA
 8:30  What the clinical oncologist needs from the pathologist? 
C. Doglioni, IT
 9:00  Management of low grade lymphoma
H. Khaled, EG
 9:30  Management of high grade lymphoma
E. Zucca, CH
 10:00   Tumour board (2-3 cases)
 11:00  Coffee break
GYNAECOLOGICAL CANCERS
Chairs: J. Vermorken, NL - S. Sahraoui, MA
 11:30  Systemic management of epithelial ovarian cancer: where do we stand today?
J. Vermorken, NL
 12:00  Systemic therapy of cervical carcinoma: any progress ?
J. Vermorken, NL
 12:30   Tumour board (2-3 cases)
 13:30  Spotlight: Cancer of unknown primary 
N. Pavlidis, GR
 14:00   Lunch break
Chairs: G. Ceresoli, IT - N. Benchakroun, MA
 15.00   Spotlight: Renal cancer
G. Ceresoli, IT
15:30  Spotlight: Current treatment and perspective in stage IV melanoma
O. Michielin, CH
 16:00  Exam
 17:00  Closing remarks